ArticleBreast (Edinburgh, Scotland)2026
Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort.
Thomas Grinda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.